CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Glenmark Pharmaceuticals Inc., USA recalls Ondansetron Orally…

Glenmark Pharmaceuticals Inc., USA recalls Ondansetron Orally Disintegrating Tablets

Read the official FDA notice

Published
7 Jan 2026
Units affected
96,948 packs
Agency
FDA
Country
United States

The hazard

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13

Brand / company
Glenmark Pharmaceuticals Inc., USA
Codes / lots
Lot #: 19251311, Exp Date April 2027
Distribution
Nationwide within the United States
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 7 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.